Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise ...
A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...
The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback